Market Risers: PetroNeft Resources, Royal Dutch Shell, Smith & Nephew

Broker Ratings

Shares of PetroNeft Resources with EPIC code: LON:PTR has moved up 4.87% or 0.18 points throughout the session so far. Traders have so far held a positive outlook during the session. The period high has peaked at 3.99 and hitting a low of 3.7. The number of shares traded by this point in time totalled 922,343 with the daily average number around 747,820. A 52 week share price high is 4.7 some 0.9 points difference from the previous days close and putting the 52 week low at 0.5 which is a variance of 3.3 points. PetroNeft Resources has a 20 SMA of 3.79 and a 50 day moving average of 3.66. Market capitalisation for the company is £44.83m at the time of this report. The currency for this stock is Great British pence.Market cap is measured in GBP. This article was written with the last trade for PetroNeft Resources being recorded at Tuesday, September 28, 2021 at 1:12:20 PM GMT with the stock price trading at 3.99 GBX.

The trading price for Royal Dutch Shell with company EPIC: LON:RDSA has gained 3.73% or 59.6 points throughout today’s trading session so far. Market buyers have stayed positive during this period. The periods high has reached 1659 and a low of 1606.4. The total volume of shares exchanged so far has reached 3,357,216 while the daily average number of shares exchanged is 12,470,715. The 52 week high for the share price is 1659 amounting to 61.4 points difference from the previous close and the 52 week low at 878.1 which is a difference of 719.5 points. Royal Dutch Shell now has a 20 moving average of 1478.06 with a 50 day MA at 1459.38. The market cap now stands at £150,547.77m at the time of this report. All share prices mentioned for this stock are traded in GBX. Mcap is measured in GBP. This article was written with the last trade for Royal Dutch Shell being recorded at Tuesday, September 28, 2021 at 1:31:23 PM GMT with the stock price trading at 1657.2 GBX.

Shares of Smith & Nephew EPIC code: LON:SN has stepped up 1.07% or 14.17 points during today’s session so far. Market buyers have remained positive while the stock has been in play. The periods high has already touched 1344.5 dropping as low as 1318.5. The total volume of shares exchanged through this period comes to 535,664 with the average number of shares traded daily being 2,155,674. A 52 week share price high is 1681.5 around 351.5 points different to the previous business close and a 52 week low sitting at 1294 making a difference of 36 points. Smith & Nephew now has a 20 moving average of 1369.62 and now a 50 day MA at 1417.69. Market capitalisation for the company is £11,847.72m at the time of this report. The share price is in Great British pence. Mcap is measured in GBP. This article was written with the last trade for Smith & Nephew being recorded at Tuesday, September 28, 2021 at 1:30:48 PM GMT with the stock price trading at 1344.17 GBX.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Smith & Nephew CFO John Rogers to step down in September

Smith & Nephew has announced John Rogers will leave as chief financial officer, with Pierre Palassian appointed interim CFO until a successor is named.

Smith & Nephew and Imperial College London open surgical robotics innovation centre

Smith & Nephew and Imperial College London have launched a five-year partnership to accelerate research and innovation in robotic surgery.

Smith & Nephew maintains profit guidance as H1 trading margin improves

Smith & Nephew reported higher half-year revenue, operating profit and cash generation, while reducing full-year revenue guidance.

Smith & Nephew reports steady Q1 growth and confirms 2026 outlook

Underlying revenue grew 3.1% in Q1, supported by innovation and strong Sports Medicine performance. The company maintains its full-year targets and unveils a new $500m buyback program.

Smith & Nephew to host Surgeon Insights event in London

Smith & Nephew will host an investor event in London featuring US surgeons discussing innovation platforms across sports medicine, wound care, and orthopaedics, with presentations and Q&A sessions led by company leadership.

Smith & Nephew delivers higher profits and cash generation in 2025

Smith+Nephew reported full-year 2025 revenue of $6.16 billion, up 6.1% on a reported basis, with trading profit rising 15.5% and free cash flow increasing 52.5%.

Search